Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.4 to v3.5.5. This represents a small software release and does not change study data or how information is displayed.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.3 to v3.5.4 to indicate deployed template updates; no substantive content changes are reflected in this change.
    Difference
    0.1%
    Check dated 2026-05-14T22:32:54.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a newer version of the page metadata. There are no visible changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-05-07T18:28:49.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:22:34.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision labels were updated from v3.4.3 to v3.5.0. There are no visible changes to study details or content.
    Difference
    0.1%
    Check dated 2026-03-25T20:07:56.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:51:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.